Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Recent clinical studies demonstrate that in trial participants with general obesity, tirzepatide results in an average body weight loss of 21% after 18 months as compared to 3% for subjects receiving placebo
This is relevant because hyperuricemia is common in people with obesity and metabolic syndrome, and elevated uric acid is associated with gout and cardiovascular risk
Anita Clayton, a psychiatrist and sexual health researcher, emphasizes: "In clinical trials, PT-141 significantly improves desire and reduces distress in premenopausal women with HSDD, offering hope for those who haven't responded to other therapies."[2] Dave Asprey highlights synergies: "PT-141 creates buzz for enhancement, especially when combined with biohacks like HRT for comprehensive optimization in menopause."[18] Dr
Best for those wanting clinically-validated comprehensive support
Early progress often depends on dose adjustments, diet, and individual response
What does it help with
US$ 21.78
US$ 22.00
US$ 25.40
US$ 21.28
US$ 26.92
